FDA Declines to Approve Epinephrine Nasal Spray, Asks for Additional Data

An FDA advisory committee in May had recommended the agency approve ARS Pharmaceuticals’ Neffy spray. The Food and Drug Administration declined to approve ARS Pharmaceuticals ’ epinephrine nasal spray and asked the company to submit more data proving the medication was safe and effective,…#fda #arspharmaceuticals
Source: Reuters: Health - Category: Consumer Health News Source Type: news